ANDOVER, Mass., Nov. 5, 2012 /PRNewswire/ -- Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced Nidia Quillinan, Ph.D., a post-doctoral fellow at The Colorado Clinical and Translational Sciences Institute at the University of Colorado, Denver, as the recipient of the sixth annual American Heart Association (AHA)-Philips Resuscitation Fellowship Award.
The Fellowship Award provides a $100,000 grant, funded by Philips over two years, and is presented annually to a researcher in the early stages of his or her career to pursue basic and clinical research related to cardiac resuscitation. The AHA selected Dr. Quillinan based on the merits of her research proposal. Philips chose to support the award due to its applicability to the field of resuscitation.
This year's grant will allow Dr. Quillinan to pursue research on global transient ischemia caused by a heart attack. Dr. Quillinan will examine how the condition affects Purkinje cells, which are the brain cells responsible for motor coordination and learning, and synaptic plasticity, or the way the synapses between cells change. The correlation between resuscitation and Purkinje cells is a recent discovery and the opportunities and consequences of this relationship remain unknown.
"Philips has a legacy of cardiac resuscitation innovations and accomplishments that spans more than 50 years," said Derek Smith, senior vice president and general manager, Therapeutic Care, Philips Healthcare. "The AHA fellowship award allows the research community to share in our dedication to saving lives by advancing knowledge of cardiac resuscitation. We are confident Dr. Quillinan's research will uncover new evidence that will benefit the medical and patient community."
The Fellowship Award was presented to Dr. Quillinan on November 3 at the Resuscitation Science Symposium (ReSS) meeting in Los Angeles. This annual event is held in conjunction with the AHA's Scientific Sessions.
Philips is a global leader in emergency care and cardiac resuscitation solutions. In addition to being the worldwide leader for automated external defibrillators (AEDs), Philips also offers advanced life support (ALS) monitors, cardiographs, cardiology informatics, cardiac imaging systems and temperature modulation therapy to help give patients the best cardiac care possible. Philips' innovative solutions support patients through every step of the cardiology care continuum, helping to prevent information delays and shorten critical care times.
To learn more about Philips' resuscitation solutions visit www.philips.com/resuscitation.
About Royal Philips Electronics Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2011 sales of EUR 22.6 billion and employs approximately 121,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming, home and portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.
SOURCE Royal Philips Electronics